Human menopausal gonadotropin-induced bioprosthetic valve thrombosis

Bioprosthetic valve thrombosis (BPVT) is a rare but potentially life-threatening complication. Human menopausal gonadotropin (hMG) is commonly used for ovulation induction and has been associated with arterial and venous thrombosis. We reported a case of BPVT related to in vitro fertilization in a 3...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rami Mahmood Abazid, Mohamed Shoman, Osama A Smettie, Osama A. Elamin
Formato: article
Lenguaje:EN
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2018
Materias:
R
Acceso en línea:https://doaj.org/article/0675a94e5dd24ddda6dd1cc45f36ae8e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0675a94e5dd24ddda6dd1cc45f36ae8e
record_format dspace
spelling oai:doaj.org-article:0675a94e5dd24ddda6dd1cc45f36ae8e2021-12-02T16:27:07ZHuman menopausal gonadotropin-induced bioprosthetic valve thrombosis2231-07702249-446410.4103/ajm.AJM_83_18https://doaj.org/article/0675a94e5dd24ddda6dd1cc45f36ae8e2018-07-01T00:00:00Zhttp://www.thieme-connect.de/DOI/DOI?10.4103/ajm.AJM_83_18https://doaj.org/toc/2231-0770https://doaj.org/toc/2249-4464Bioprosthetic valve thrombosis (BPVT) is a rare but potentially life-threatening complication. Human menopausal gonadotropin (hMG) is commonly used for ovulation induction and has been associated with arterial and venous thrombosis. We reported a case of BPVT related to in vitro fertilization in a 39-year-old female, who underwent redo mitral valve replacement. To the best of our knowledge, this is the first case of hMG-induced BPVT in a young female patient.Rami Mahmood AbazidMohamed ShomanOsama A SmettieOsama A. ElaminThieme Medical and Scientific Publishers Pvt. Ltd.articlebioprosthetic valve thrombosishuman menopausal gonadotropinin vitro fertilizationMedicineRENAvicenna Journal of Medicine, Vol 8, Iss 03, Pp 114-116 (2018)
institution DOAJ
collection DOAJ
language EN
topic bioprosthetic valve thrombosis
human menopausal gonadotropin
in vitro fertilization
Medicine
R
spellingShingle bioprosthetic valve thrombosis
human menopausal gonadotropin
in vitro fertilization
Medicine
R
Rami Mahmood Abazid
Mohamed Shoman
Osama A Smettie
Osama A. Elamin
Human menopausal gonadotropin-induced bioprosthetic valve thrombosis
description Bioprosthetic valve thrombosis (BPVT) is a rare but potentially life-threatening complication. Human menopausal gonadotropin (hMG) is commonly used for ovulation induction and has been associated with arterial and venous thrombosis. We reported a case of BPVT related to in vitro fertilization in a 39-year-old female, who underwent redo mitral valve replacement. To the best of our knowledge, this is the first case of hMG-induced BPVT in a young female patient.
format article
author Rami Mahmood Abazid
Mohamed Shoman
Osama A Smettie
Osama A. Elamin
author_facet Rami Mahmood Abazid
Mohamed Shoman
Osama A Smettie
Osama A. Elamin
author_sort Rami Mahmood Abazid
title Human menopausal gonadotropin-induced bioprosthetic valve thrombosis
title_short Human menopausal gonadotropin-induced bioprosthetic valve thrombosis
title_full Human menopausal gonadotropin-induced bioprosthetic valve thrombosis
title_fullStr Human menopausal gonadotropin-induced bioprosthetic valve thrombosis
title_full_unstemmed Human menopausal gonadotropin-induced bioprosthetic valve thrombosis
title_sort human menopausal gonadotropin-induced bioprosthetic valve thrombosis
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
publishDate 2018
url https://doaj.org/article/0675a94e5dd24ddda6dd1cc45f36ae8e
work_keys_str_mv AT ramimahmoodabazid humanmenopausalgonadotropininducedbioprostheticvalvethrombosis
AT mohamedshoman humanmenopausalgonadotropininducedbioprostheticvalvethrombosis
AT osamaasmettie humanmenopausalgonadotropininducedbioprostheticvalvethrombosis
AT osamaaelamin humanmenopausalgonadotropininducedbioprostheticvalvethrombosis
_version_ 1718383973294407680